期刊文献+

脑小血管病的生物学标志物 被引量:7

Biomarkers of cerebral small vessel disease
原文传递
导出
摘要 脑小血管病(cerebral small vessel disease,CSVD)是指各种病因所致的影响脑组织微动脉、小动脉、小静脉和毛细血管的一组病理学过程。炎症和血管内皮功能障碍在导致CSVD相关性改变的机制中可能发挥重要作用,相关领域的研究有望成为深入了解CSVD的重要手段。CSVD导致脑组织功能障碍的驱动因素以及血管病变和原发性神经变性改变在导致CSVD过程中所起的相对作用尚不清楚。反映中枢神经系统变性病变和血管病变过程的脑脊液成分检查可提供重要信息。相关生化改变可能成为CSVD的早期识别指标,同时可增进对其特征性机制的了解。此外,CSVD特异性生物学标志物还能在监测治疗效果方面发挥重要作用。 Cerebral small vessel disease (CSVD) refers to a group of pathological processes caused by various causes that affect the microarteries, small arteries, venules and capillaries in brain tissue. Inflammation and endothelial dysfunction may play an important role in mechanism of leading to CSVD- related changes. The research in related fields is expected to become an important means of in-depth understanding of CSVD. The driving factors of brain dysfunction caused by CSVD and the relative role of vascular lesions and primary neurodegenerative changes in the process of CSVD remain unclear. The examinations reflecting cerebrospinal fluid components of the central nervous system degenerative lesions and vascular lesion process can provide important information. The related biochemical changes may become an early identification indicator of CSVD, at the same time it can enhance the understanding of its characteristic mechanism. In addition, CSVD specific biomarkers can also play an important role in monitoring the therapeutic effects.
作者 顾雨铖 徐运
出处 《国际脑血管病杂志》 2017年第3期251-257,共7页 International Journal of Cerebrovascular Diseases
基金 科学技术部“十三五”慢性病防控专项(2016YFC1300504) 江苏省科学技术厅医学重点项目(BE2016610) 江苏省医学重点学科
关键词 脑小血管疾病 生物标志物 氧化性应激 炎症 血脑屏障 Cerebral Small Vessel Diseases Biomarkers Oxidative Stress Inflammation Blood-Brain Barrier
  • 相关文献

参考文献2

二级参考文献40

  • 1Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging [ J ]. Lancet Neurol, 2013, 12: 483-497.
  • 2Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic cha//enges [ J ]. Lancet Neurol, 2010, 9: 689-701.
  • 3Moran C, Phan TG, Srikanth VK. Cerebral small vessel disease: a review of clinical, radiological, and histopathological phenotypes [J]. Int J Stroke, 2012, 7: 36-46.
  • 4Hainsworth AH, Oommen AT, Bridges LR. Endothelial cells and human cerebral small vessel disease[ J ]. Brain Pathol, 2015, 25: 44-50.
  • 5Schreiber S, Bueche CZ, Garz C, et al. lood brain barrier breakdown as the starting point of cerebral small vessel disease? New insights from a rat model[J]. Exp Transl Soke Meal, 2013, 5: 4.
  • 6Kaffashian S, Tzourio C, Soumar A, et al. Plasma [3-amyloid and MRI markers of cerebral small vessel disease: Three-City Dijon study [J]. Neurology, 2014, 83: 2038-2045.
  • 7Shoamanesh A, Preis SR, Beiser AS, et al. Inflammatory biomarkers, cerebral mierobleeds, and small vessel disease: Framingham Heart Study[ J ]. Neurology, 2015, 84: 825-832.
  • 8Hart JH, Wong KS, Wang YY, et al. Plasma level of sICAM-1 is associated with the extent of white matter lesion among asymptomatic elderly subjects [ J ]. Clin Neurol Neurosurg, 2009, 111: 847-851.
  • 9Rouhl RP, Darnoiseaux JG, Lodder J, et al. Vascular inflammation in cerebral small vessel disease[ J]. Neurobiol Aging, 2012, 33: 1800- 1806.
  • 10Wiseman S, Marlborough F, Doubal F, et al. Blood markers of coagulation, fibrinolysis, endothelial dysfunction and inflammation in lacunar stroke versus non-lacunar stroke and non-stroke: systematic review and meta-analysis [J ]. Cerebrovasc Dis, 2014, 37: 64-75.

共引文献12

同被引文献48

引证文献7

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部